It is now considered the “gold standard therapy” in both pre- and post-menopausal women for the effective treatment of estrogen-positive BC [4], and its mechanism of action includes attachment to estrogen receptors, thereby instigating a conformational change and finally inducing a change in the expression of the genes associated with estrogen [11]. This evidence concerns the gene ESR1 and breast cancer.